Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 401–500 of 1,000
Review of Inhaled Nitric Oxide in the Pediatric Cardiac Surgery Setting
Checchia, P. A., Bronicki, R. A., & Goldstein, B. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0172-4 · Cited by 56
Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death
Singla, S., Sysol, J. R., Dille, B., Jones, N., Chen, J., & Machado, R. F. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0287oc · Cited by 55
Blood rheological abnormalities in sickle cell anemia
Connes, P., Renoux, C., Romana, M., Abkarian, M., Joly, P., Martin, C., Hardy‐Dessources, M., & Ballas, S. K. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189005 · Cited by 56
“In support of these mechanisms, plasma from patients with SCA contains cell-free ferrous oxyhemoglobin, which stoichiometrically consumes micromolar quantities of NO and abrogates forearm blood flow response to NO donor infusion [50].”
Zhou, T., Ashley, J. A., Feng, X., & Sun, Y. (2018) · Talanta · doi:10.1016/j.talanta.2018.08.030 · Cited by 55
“It is important to monitor Hb as numerous diseases are associated with Hb, such as thalassemia, sickle cell disease and emphysema [1,2].”
Backgroundde Oliveira, J., Denadai, M. B., & Costa, D. L. (2022) · Antioxidants · doi:10.3390/antiox11050861 · Cited by 67
Cerebral oximetry in patients with sickle cell disease
Nahavandi, M., Tavakkoli, F., Hasan, S., Wyche, M. Q., & Castro, O. L. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01307.x · Cited by 54
Genetic determinants of haemolysis in sickle cell anaemia
Milton, J. N., Rooks, H., Drasar, E., McCabe, E. L., Baldwin, C. T., Melista, E., Gordeuk, V. R., Nouraie, M., Kato, G. R., Minniti, C., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12245 · Cited by 53
“…by showing that the haemolytic score was significantly associated with plasma red blood cell micro particles and cell-free haemoglobin concentration, both of which are more direct markers of intravascular haemolysis in sickle cell disease (Cannan, 1958; Reiter et al, 2002; Nouraie et al, 2012).”
BackgroundSelf-citationNitric Oxide Synthetic Pathway in Red Blood Cells Is Impaired in Coronary Artery Disease
Eligini, S., Porro, B., Lualdi, A., Squellerio, I., Veglia, F., Chiorino, E., Crisci, M., Garlaschè, A., Giovannardi, M., Werba, J. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066945 · Cited by 57
“Initially, it was hypothesized that RBCs serve as scavengers or transporters for NO produced by endothelial cells [28] but, recently, an active role of RBCs in NO biosynthesis has been recognized [5].”
BackgroundVasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses
Belcher, J. D., Nath, K. A., & Vercellotti, G. M. (2013) · ISRN Oxidative Medicine · doi:10.1155/2013/831596 · Cited by 56
“Excessive release of HbS from sickle RBC into plasma can lead to the depletion of plasma haptoglobin, hemopexin and NO [62, 63], deposition of heme iron in cells and a proinflammatory/prothrombotic phenotype that promotes episodic painful vasoocclusive crises leading to ischemia/reperfusion injury and organ infarction.”
BackgroundNew insights into sickle cell disease
Sun, K., & Xia, Y. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f55f9 · Cited by 66
“041 g/dl during vasoocclusive crisis in SCD patient plasma [39,40].”
BackgroundKucukal, E., Ilich, A., Key, N. S., Little, J. A., & Gurkan, U. A. (2018) · American Journal of Hematology · doi:10.1002/ajh.25159 · Cited by 56
Regulation of nitric oxide consumption by hypoxic red blood cells
Han, T. H., Qamirani, E., Nelson, A. G., Hyduke, D. R., Chaudhuri, G., Kuo, L., & Liao, J. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133409100 · Cited by 54
Pathobiology of Transfusion Reactions
Zimring, J. C., & Spitalnik, S. L. (2015) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040318 · Cited by 61
Erlandsson, L., Masoumi, Z. T., Hansson, L. R., & Hansson, S. R. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13349 · Cited by 56
Wang, D., Cortés‐Puch, I., Sun, J., Solomon, S. B., Kanias, T., Remy, K. E., Feng, J. H., Alimchandani, M., Quezado, M., Helms, C. C., et al. (2014) · Transfusion · doi:10.1111/trf.12607 · Cited by 57
Self-citationKe, Z., & Huang, Q. (2016) · Scientific Reports · doi:10.1038/srep26982 · Cited by 53
Hematological disorders and pulmonary hypertension
Mathew, R., Huang, J. L., WU, J. M., Fallon, J. T., & Gewitz, M. H. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i12.703 · Cited by 58
Gomperts, E. D., Belcher, J. D., Otterbein, L. E., Coates, T. D., Wood, J. C., Skolnick, B. E., Levy, H. A., & Vercellotti, G. M. (2017) · American Journal of Hematology · doi:10.1002/ajh.24750 · Cited by 55
“Free Hb in the vasculature rapidly quenches the vasodilator nitric oxide (NO) resulting in vasospasm.(6,7) In the pro-oxidative SCD vasculature, the reaction of NO and other oxidants with ferrous”
BackgroundElahi, M. M., Naseem, K. M., & Matata, B. M. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05660.x · Cited by 48
A Perspective on the Role of Extracellular Hemoglobin on the Innate Immune System
Lee, S. K., & Ding, J. L. (2013) · DNA and Cell Biology · doi:10.1089/dna.2012.1897 · Cited by 52
“…released cell-free Hb scavenges NO, which normally plays an important beneficial role in vascular homeostasis, without which, smooth muscle dystonia, vasculopathy, thrombosis, endothelial dysfunction, and platelet aggregation may ensue (Reiter et al., 2002; Olson et al., 2004; Rother et al., 2005).”
BackgroundThe role of the arginine metabolome in pain: implications for sickle cell disease
Morris, C. R., & Bakshi, N. (2016) · Journal of Pain Research · doi:10.2147/jpr.s55571 · Cited by 57
Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury
Rubio‐Navarro, A., Vázquez‐Carballo, C., Guerrero‐Hue, M., García‐Caballero, C., Herencia, C., Gutiérrez, E., Yuste, C., Sevillano, Á., Praga, M., Egea, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00740 · Cited by 52
Medical gas plasma promotes blood coagulation via platelet activation
Bekeschus, S., Poschkamp, B., & van der Linde, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120433 · Cited by 53
Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism
Buehler, P. W., Baek, J. H., Lisk, C., Connor, I., Sullivan, T., Kominsky, D. J., Majka, S. M., Stenmark, K. R., Nozik‐Grayck, E., Bonaventura, J., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00074.2012 · Cited by 52
Nitric oxide pathology and therapeutics in sickle cell disease
Kim‐Shapiro, D. B., & Gladwin, M. T. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189009 · Cited by 55
“That inhaled NO, which decreases NO scavenging by cell-free Hb through conversion to methemoglobin [105], improves vascular NO response argues for a central role of direct scavenging by cell-free Hb in low NO bioavailabilty in SCD.”
InfluentialSelf-citationAlternate and Additional Functions of Erythrocyte Hemoglobin
Kosmachevskaya, O. V., & Topunov, A. F. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120155 · Cited by 64
Sandrim, V. C., Montenegro, M. F., Palei, A. C., Metzger, I. F., Sertorio, J. T. C., Cavalli, R. D. C., & Tanus-Santos, J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.012 · Cited by 56
Self-citationKlings, E. S., Anton Bland, D., Rosenman, D., Princeton, S., Odhiambo, A., Li, G., Bernard, S. A., Steinberg, M. H., & Farber, H. W. (2008) · American Journal of Hematology · doi:10.1002/ajh.21187 · Cited by 51
“PH in SCD is associated with increased hemolysis [13–16,35,36], a decrease in the NO precursor, L-arginine [5,19,37], reduced NO bioavailability [8,9,15] and a disruption of the coagulation cascade.”
BackgroundHeme: The Lord of the Iron Ring
Voltarelli, V. A., de Souza, R. W. A., Miyauchi, K., Hauser, C. J., & Otterbein, L. E. (2023) · Antioxidants · doi:10.3390/antiox12051074 · Cited by 57
“One of the reasons is that these patients present increased circulating levels of ferrous heme and hemoglobin, which scavenge nitric oxide (NO), a potent vasodilator [123].”
BackgroundMolecular Pathophysiology of Priapism: Emerging Targets
Anele, U. A., Morrison, B. F., & Burnett, A. L. (2014) · Current Drug Targets · doi:10.2174/1389450115666141111111842 · Cited by 54
“Hemoglobin then avidly scavenges intravascular NO causing a decrease in normal levels [21, 22].”
BackgroundExercise training blunts oxidative stress in sickle cell trait carriers
Chirico, E. N., Martin, C., Faës, C., Féasson, L., Oyono-Enguéllé, S., Aufradet, É., Dubouchaud, H., Francina, A., Canet‐Soulas, E., Thiriet, P., et al. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01452.2011 · Cited by 57
“An impaired NO bioavailability is associated with an increase in ROS, hemolysis (58), eNOS uncoupling due to hemolysis-induced arginase, and cell adhesion (35).”
BackgroundGrubina, R., Basu, S., Tiso, M., Kim-Shapiro, D. B., & Gladwin, M. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705222200 · Cited by 50
Self-citationRusanova, I., Escames, G., Cossio, G., Borace, R. G. D., Moreno, B., Chahboune, M., López, L. C., Diez, T. A., & Acuña-Castroviejo, D. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01528.x · Cited by 56
“Hypertension in patients with SCD was related to ROS, which can directly deactivate endothelial nitric oxide synthase (eNOS) (11), reducing nitric oxide (NO·) levels (12), an important vasodilator.”
BackgroundInnate Immune Activation After Transfusion of Stored Red Blood Cells
Neal, M. D., Raval, J. S., Triulzi, D. J., & Simmons, R. L. (2013) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2013.01.001 · Cited by 50
Increased Pulmonary Pressures and Myocardial Wall Stress in Children with Severe Malaria
Janka, J., Koita, O., Traoré, B., Traoré, J. M., Mzayek, F., Sachdev, V., Wang, X., Sanogo, K. M., Sangaré, L., Mendelsohn, L. G., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655225 · Cited by 50
“001) [16,19], and was greater for cases than controls (medians of 11.”
BackgroundMethodSelf-citationDasgupta, T., Fabry, M. E., & Kaul, D. K. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00611.2009 · Cited by 50
Endothelial Function in Patients with Sickle Cell Anemia During and After Sickle Cell Crises
Blum, A., Yeganeh, S., Peleg, A., Vigder, F., Kryuger, K., Khatib, A., Khazim, K., & Dauerman, H. L. (2005) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-1377-7 · Cited by 50
Haptoglobin improves shock, lung injury, and survival in canine pneumonia
Remy, K. E., Cortés-Puch, I., Solomon, S. B., Sun, J., Pockros, B. M., Feng, J., Lertora, J. J., Hantgan, R. R., Liu, X., Perlegas, A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123013 · Cited by 49
Self-citation2015 Clinical trials update in sickle cell anemia
Archer, N. M., Galactéros, F., & Brugnara, C. (2015) · American Journal of Hematology · doi:10.1002/ajh.24116 · Cited by 58
“The chronic hemolytic state of SCD increases plasma Hb values and substantially limits NO bioavailability, resulting in a NO-deficient state [121].”
BackgroundChintagari, N. R., Jana, S., & Alayash, A. I. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0197oc · Cited by 53
“Severe vasoconstriction due to nitric oxide sequestration by Hb is thought to be a cause of Hb-induced toxicity in hemolytic anemias and in therapeutic uses of Hb (6, 7).”
BackgroundPremature atherosclerosis in children with beta-thalassemia major: New diagnostic marker
Sherief, L. M., Dawood, O., Ali, A. S. A., Sherbiny, H. S., Kamal, N. M., El-Shanshory, M. R., Alazez, O. A., Alhady, M. A., Nour, M., & Mokhtar, W. A. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0820-1 · Cited by 55
“These metabolic derangements limit the availability of arginine to nitric oxide synthase and lead to vascular dysfunction by disturbing the bioavailability of nitric oxide (NO) [24, 25].”
BackgroundAlexander, J. T., El-Ali, A. M., Newman, J. L., Karatela, S., Predmore, B. L., Lefer, D. J., Sutliff, R. L., & Roback, J. D. (2013) · Transfusion · doi:10.1111/trf.12111 · Cited by 53
Targeting iNKT cells for the treatment of sickle cell disease
Field, J. J., Nathan, D. G., & Linden, J. M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.03.002 · Cited by 50
Jones, K. M., Niaz, M. S., Brooks, C. M., Roberson, S. I., Aguinaga, M. D. P., Hills, E. R., Rice, V. M., Bourne, P., Bruce, D. F., & Archibong, A. E. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6031124 · Cited by 51
“For this to occur, HU must be metabolized by the liver to nitric oxide [56], a radical that has important consequences for the pathophysiology and treatment of SCD [57-60] albeit with a detrimental effect on a major spermatogenesis regulatory hormone, testosterone.”
BackgroundSickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology
Lizarralde-Iragorri, M. A., & Shet, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155279 · Cited by 49
“As described below, sickle hemolysis can consume vascular nitric oxide (NO) and plasma arginine, inducing profound endothelial and vascular dysfunction [70,71].”
BackgroundThe Red Blood Cell and Vascular Function in Health and Disease
Crawford, J. H., Chacko, B. K., Kevil, C. G., & Patel, R. P. (2004) · Antioxidants and Redox Signaling · doi:10.1089/1523086042259869 · Cited by 49
High Prevalence of Pulmonary Hypertension in Children With Sickle Cell Disease
Nelson, S. C., Adade, B. B., McDonough, E. A., Moquist, K. L., & Hennessy, J. M. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31805d8f32 · Cited by 51
“Chronic hemolysis leads to increased cellfree hemoglobin, which destroys nitric oxide (NO) leading to pulmonary vasoconstriction.(13) This decrease in NO bioavailability leads to an increased expression of soluble endothelial-derived adhesion molecules, further complicating pulmonary vascular flow.”
BackgroundRole of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases
Mehta, N. U., & Reddy, S. T. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000208 · Cited by 48
“Increased circulating ferrous heme containing Hb scavenges nitric oxide, a potent vasodilator [22]; promotes the generation of ROS, which leads to endothelial activation [23]; and induces smooth muscle proliferation [24], contributing further to cardiovascular disease [25].”
Nur, E., Brandjes, D. P. M., Schnog, J. B., Otten, H.-M. M. B., Fijnvandraat, K., Schalkwijk, C. G., Biemond, B. J., & the CURAMA Study Group (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08320.x · Cited by 52
“…cell disease (SCD) is characterized by unstable autooxidative sickle haemoglobin (HbS) (Hebbel et al, 1988), chronic intravascular haemolysis (Reiter et al, 2002), recurrent ischemia reperfusion injury (Nath et al, 2005) and low grade inflammation (Akohoue et al, 2007), all contributing…”
BackgroundDahhan, A. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12106 · Cited by 47
Weinberg, J. B., Volkheimer, A. D., Rubach, M. P., Florence, S. M., Mukemba, J. P., Kalingonji, A. R., Langelier, C., Chen, Y., Bush, M. A., Yeo, T. W., et al. (2016) · Scientific Reports · doi:10.1038/srep29151 · Cited by 49
“Since lysis of erythrocytes can release arginase 1 into plasma 21 , we considered that the intravascular hemolysis accompanying schizont rupture might cause high levels of plasma arginase with consequent degradation of arginine competing with NOS for the substrate arginine.”
Hierso, R., Lemonne, N., Villaescusa, R., Lalanne‐Mistrih, M., Charlot, K., Etienne‐Julan, M., Tressières, B., Lamarre, Y., Tarer, V., Garnier, Y., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14476 · Cited by 47
Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
Kalpatthi, R. V., & Novelli, E. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.482 · Cited by 51
Thomas, A. M., Gerogianni, A., McAdam, M. B., Fløisand, Y., Lau, C., Espevik, T., Nilsson, P. H., Mollnes, T. E., & Barratt‐Due, A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900047 · Cited by 47
Haselden, W. D., Kedarasetti, R. T., & Drew, P. J. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008069 · Cited by 51
“However, plasma free Hgb can be elevated in sickle cell disease [88], malaria [169] or following blood transfusions [170].”
BackgroundErythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier
Han, T. H., & Liao, J. C. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.01.013 · Cited by 47
Fiser, R. T., Irby, K., Ward, R. M., Tang, X., McKamie, W., Prodhan, P., & Corwin, H. L. (2014) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000222 · Cited by 48
“Finally, stored, transfused RBC contain small quantities of free hemoglobin that act as scavengers of endogenously produced nitric oxide, perhaps resulting in small vessel vasoconstriction and thus impairing local tissue Do 2 (36, 37).”
BackgroundHemoglobinopathies and sleep – The road less traveled
Gileles‐Hillel, A., Gozal, D., & Gozal, D. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.01.002 · Cited by 48
Maître, B., Djibré, M., Katsahian, S., Habibi, A., Stankovic, K., Khellaf, M., Bourgeon, I., Lionnet, F., Charles‐Nelson, A., Brochard, L. J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4060-2 · Cited by 46
Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension
Kimmig, L. M., & Palevsky, H. I. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201512-826fr · Cited by 48
Hypoxia‐enhanced adhesion of red blood cells in microscale flow
Kim, M., Alapan, Y., Adhikari, A., Little, J. A., & Gurkan, U. A. (2017) · Microcirculation · doi:10.1111/micc.12374 · Cited by 48
“67 Hemolysis and release of heme results in abnormal endothelial activation and inflammation.(68-74) Increased levels of soluble adhesion molecules (vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), P-selectin, E-selectin, and Von Willebrand factor (VWF)), have been associated wit…”
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE: Guest Editor: Raffaella Origa
Mattè, A., Mazzi, F., Federti, E., Olivieri, O., & Franceschi, L. D. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.002 · Cited by 77
“67,69 The highly pro-oxidant environment with the presence of free heme and free Hb promotes inflammation and abnormal vascular activation with increased expression of adhesion vascular molecules such as VCAM-1, ICAM-1 or E-selectin.”
Inflammatory targets of therapy in sickle cell disease
Owusu-Ansah, A. T., Ihunnah, C. A., Walker, A. L., & Ofori-Acquah, S. F. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.001 · Cited by 46
“Haptoglobin (Hp) and Hx (which scavenge cell free Hb and heme respectively), are depleted (19), thus, the plasma of patients with SCD contains excess cellfree Hb and heme (20, 22).”
BackgroundSerum lactate dehydrogenase activity as a biomarker in children with sickle cell disease
O’Driscoll, S., Height, S. E., Dick, M. C., & Rees, D. C. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06894.x · Cited by 48
“Gladwin et al demonstrated that intravascular haemolysis results in free plasma haemoglobin (Hb), which binds avidly to, and results in a functional deficiency of, nitric oxide (NO) (Reiter et al, 2002).”
BackgroundPulmonary Hypertension Associated with Chronic Hemolytic Anemia and Other Blood Disorders
Machado, R. F., & Farber, H. W. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.006 · Cited by 47
Elevation of Plasma Cell-Free Hemoglobin in Pulmonary Arterial Hypertension
Brittain, E. L., Janz, D. R., Austin, E. D., Bastarache, J. A., Wheeler, L. A., Ware, L. B., & Hemnes, A. R. (2014) · CHEST Journal · doi:10.1378/chest.14-0809 · Cited by 48
Charlot, K., Romana, M., Möckesch, B., Jumet, S., Waltz, X., Divialle‐Doumdo, L., Hardy‐Dessources, M., Petras, M., Tressières, B., Tarer, V., et al. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.10.005 · Cited by 49
Lisk, C., Kominsky, D., Ehrentraut, S., Bonaventura, J., Nuss, R., Hassell, K. L., Nozik‐Grayck, E., & Irwin, D. C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0440oc · Cited by 45
Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases
Grünenwald, A., Roumenina, L. T., & Frimat, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042009 · Cited by 46
“Interestingly, CO (one of the by-products of heme degradation by HO-1) has been suggested as being involved in hyperperfusion and hyperfiltration (both observed in the kidney of SCA patients [121,132,133]), and may thus counterbalance the vasoconstrictive effects of NO depletion by hemoglobin scavenging [108], as well…”
BackgroundHaptoglobin Genotype-Dependent Anti-Inflammatory Signaling in CD163+Macrophages
Landis, R. C., Philippidis, P., Domin, J., Boyle, J. J., & Haskard, D. O. (2013) · International Journal of Inflammation · doi:10.1155/2013/980327 · Cited by 45
Defining stroke risk in children with sickle cell anaemia
Hoppe, C. C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05310.x · Cited by 51
“…of platelet aggregation, is decreased in SCD. Depletion of NO has been shown to occur via haemoglobin (Hb)-mediated scavenging, consumption by reactive oxygen species and arginase-mediated substrate depletion (Aslan et al, 2001; Reiter et al, 2002; Gladwin et al, 2004; Morris et al, 2004).”
BackgroundMorris, C. R. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605010-00003 · Cited by 50
Chintagari, N. R., Nguyen, J., Belcher, J. D., Vercellotti, G. M., & Alayash, A. I. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.12.001 · Cited by 47
“reaction with NO, which also results in Hb oxidation [29].”
BackgroundAkel, S. M., Regan, D. M., Wall, D. A., Petz, L., & McCullough, J. (2014) · Transfusion · doi:10.1111/trf.12719 · Cited by 47
Solovey, A. N., Kollander, R., Milbauer, L. C., Abdulla, F. A., Chen, Y., Kelm, R. J., & Hebbel, R. P. (2009) · American Journal of Hematology · doi:10.1002/ajh.21582 · Cited by 46
Temperature-touch interaction: Weber's phenomenon revisited.
Stevens, J., & Green, B. G. (1978) · PubMed · Cited by 45
Role of Circulating S -Nitrosothiols in Control of Blood Pressure
Foster, M. W., Pawloski, J. R., Singel, D. J., & Stamler, J. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000150160.41992.71 · Cited by 45
Nitric oxide inhibits the pannexin 1 channel through a cGMP–PKG dependent pathway
Poornima, V., Vallabhaneni, S., Mukhopadhyay, M., & Bera, A. K. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.04.005 · Cited by 43
Cheung, Y., Chow, P., Chan, G., & Ha, S. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06349.x · Cited by 48
“Furthermore, cell-free haemoglobin has recently been implicated in mediating vascular dysfunction by limiting nitric oxide bioavailability in haemolytic disease (Reiter et al, 2002).”
BackgroundVascular risk assessment in patients with sickle cell disease
Morris, C. R. (2010) · Haematologica · doi:10.3324/haematol.2010.035097 · Cited by 49
“The simultaneous release of erythrocyte arginase during hemolysis11 will limit the availability of arginine to NO synthase, contributing to a deficiency of NO.”
BackgroundInfluentialBrandow, A. M., Wandersee, N. J., Dasgupta, M., Hoffmann, R. G., Hillery, C. A., Stucky, C. L., & Panepinto, J. A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14300 · Cited by 47
“We investigated this association because the degree of haemolysis in SCD patients has been associated with a variety of sickle cell-related complications (Reiter et al, 2002; Gladwin et al, 2004; Kato et al, 2006, 2007; Taylor et al, 2008; Rees et al, 2010).”
BackgroundDrug Therapies for the Management of Sickle Cell Disease
Rai, P., & Ataga, K. I. (2020) · F1000Research · doi:10.12688/f1000research.22433.1 · Cited by 51
Pharmacotherapy in sickle cell disease – state of the art and future prospects
Hankins, J. S., & Aygün, B. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07602.x · Cited by 48
“The ongoing intravascular haemolysis that occurs in SCD rapidly inactivates NO via destruction by cell-free haemoglobin and also by a reaction between ferrous iron and ferric iron, which forms nitrosylhaemoglobin that consumes NO (Reiter et al, 2002).”
BackgroundClaudino, M. A., Franco‐Penteado, C. F., Corat, M. A. F., Gimenes, A. P., Passos, L. A. C., Antunes, E., & Costa, F. F. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01337.x · Cited by 43
Red blood cell transfusions in acute paediatrics
Morley, S. L. (2009) · Archives of Disease in Childhood Education & Practice · doi:10.1136/adc.2007.135731 · Cited by 43
“Free haemoglobin is a potent scavenger of NO that causes vasoconstriction.(25) Storage of RBCs also increases their adherence to vascular endothelium and may reduce microvascular flow,(26) although this effect may be reduced by pre-storage leucodepletion.”
Gram, M., Anderson, U. D., Johansson, M. E., Anneli, E.-H., Larsson, I., Jälmby, M., Hansson, S. R., & Åkerström, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138111 · Cited by 46
“Long-term exposure to cell-free Hb and heme has been described to be associated with NO depletion, inflammation and oxidative stress [44,45].”
BackgroundMartins, Y. C., Zaniní, G. M., Frangos, J. A., & Carvalho, L. J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032048 · Cited by 46
“It is not know whether L-arginine infusion would have the same effect in the latter group since free hemoglobin stoichiometrically consumes micromolar quantities of NO [52,53].”
BackgroundHaptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis
Kerchberger, V. E., Bastarache, J. A., Shaver, C. M., Nagata, H., McNeil, J. B., Landstreet, S. R., Putz, N. D., Yu, W.-K., Jesse, J. J., Wickersham, N. E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131206 · Cited by 46
The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
Hannemann, A., Weiss, E., Rees, D. C., Dalibalta, S., Ellory, J. C., & Gibson, J. S. (2010) · Anemia · doi:10.1155/2011/248527 · Cited by 45
“Intravascular haemolysis is observed and the consequent release of Hb to circulate freely in plasma contributes to the vasculopathy, probably by scavenging nitric oxide (NO) and causing a functional deficiency of that molecule [22, 23].”
BackgroundAtaga, K. I., Derebail, V. K., Caughey, M. C., Elsherif, L., Shen, J. H., Jones, S., Maitra, P., Pollock, D. M., Cai, J., Archer, D. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162652 · Cited by 44
Turpin, M., Chantalat‐Auger, C., Parent, F., Driss, F., Lionnet, F., Habibi, A., Maître, B., Huertas, A., Jaïs, X., Weatherald, J. C., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00272-2018 · Cited by 42
Gentinetta, T., Belcher, J. D., Brügger‐Verdon, V., Adam, J., Ruthsatz, T., Bain, J., Schu, D. J., Ventrici, L., Edler, M., Lioe, H., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030630 · Cited by 45
“As this hemoglobin becomes oxidized or denatured, it is prone to release extracellular free heme [7,8].”
BackgroundNitric Oxide in Cerebral Vasospasm: Theories, Measurement, and Treatment
Siuta, M., Zuckerman, S. L., & Mocco, J. (2013) · Neurology Research International · doi:10.1155/2013/972417 · Cited by 43
“This basic concept is supported by studies of patients with sickle cell disease, which demonstrate that hemoglobin, when it is outside of red blood cells, acts to reduce the bioavailability of NO [48].”
BackgroundRees, D. C., Dick, M. C., Height, S. E., O'Driscoll, S., Pohl, K. R. E., Goss, D. E., & Deane, C. R. (2008) · Pediatrics · doi:10.1542/peds.2007-2771 · Cited by 40
Thrombosis in Paroxysmal Nocturnal Hemoglobinuria at a Glance: A Clinical Review
Ziakas, P. D., Poulou, L. S., & Pomoni, A. (2008) · Current Vascular Pharmacology · doi:10.2174/157016108785909742 · Cited by 41
Kirkham, F. J., & Datta, A. K. (2006) · Developmental Science · doi:10.1111/j.1467-7687.2006.00507.x · Cited by 42
Rees, D. C., Lambert, C., Cooper, E., Bartram, J., Goss, D., Deane, C., & Thein, S. L. (2009) · Blood · doi:10.1182/blood-2009-04-216861 · Cited by 41
Ekregbesi, P., Shankar‐Hari, M., Bottomley, C., Riley, E. M., & Mooney, J. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-29558-5 · Cited by 47
Long-term effect of medium cut-off dialyzer on middle uremic toxins and cell-free hemoglobin
Cho, N., Park, S., Islam, M. I., Song, H., Lee, E. Y., & Gil, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220448 · Cited by 42
Blood cell NO synthesis in response to exercise
Sureda, A., Tauler, P., Aguiló, A., Fuentespina, E., Córdova, A., Tur, J. A., & Pons, A. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.11.004 · Cited by 46
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.